Life Sciences

Jim Green will retire from his roles as chairman, president, and CEO of Harvard Bioscience on July 28.

The deal, announced in a Monday press release, seeks to accelerate Waters’ expansion into high-growth markets and deliver cost and revenue synergies.

The project will involve other site improvements, including the construction of outdoor patios, landscape improvements. A portion of Research Drive will be relocated to segregate pedestrian and truck traffic.

After months of negotiations, including those with an anonymous, unsolicited third party, Marlborough-based biotech firm Akoya Biosciences has officially been acquired by Quanterix.

Harvard Bioscience, a Holliston-based biotech firm, has fallen out of compliance with Nasdaq stock exchange requirements following the resignation of a board of directors member.

The firm is expanding its facility in Devens after designating the site as the company’s headquarters in March.

Three Central Massachusetts companies have been named among the best public companies to work for by the U.S. News & World Report.

Three Central Massachusetts companies have split more than $2 million in tax incentives as part of a broader state initiative to create new life sciences industry jobs across the commonwealth. 

Startups have navigated the perilous Valley of Death period with varying levels of success. Conifer Life Sciences Group at MBI is trying to change that.

Loewald’s departure comes after the CFO of the company resigned in May, after it reported a net loss of $12.4 million from fiscal 2024.